Johnson & Johnson announced it agreed to acquire Actelion Pharmaceuticals, Europe’s biggest biotech company, for $30 billion, or CHF280 per share, expanding the U.S. pharma giant’s…
Johnson & Johnson’s USD 30 billion acquisition of Actelion Pharmaceuticals, Europe’s biggest biotech company
